You are here / Home / News
 

TSO3: Highpoints and financial results for the fiscal year ended at December 31, 2006

March 23, 2007

Québec City, March 23, 2007 – TSO3 Inc. (TSX: TOS) announced its financial results for the fiscal year ended at December 31, 2006.

For the fiscal year ended December 31, 2006, the Company posted a net loss of $7.5 million or $0.20 per share, compared to a net loss of $6.4 million or $0.19 per share for the fiscal year 2005. This slight increase in the net loss is mainly explained by the intensification of the Company’s commercial activities.

“The year 2006 was a year of consolidation and action. We have put in place all the elements necessary for the commercialization of our first product: the 125L Ozone Sterilizer”, said Jocelyn Vézina, CEO of TSO3 Inc.

“In 2006, we strengthened the relationship with our original clients and we put in place our own sales force recruiting the best talent. Moreover, several sales were completed in the last year, and we solidified our growing base of potentials clients, assuring us a sufficient pipeline for the realization of our business plan for 2007”, he concluded.

2006 Highpoints Overview

- After having put in place its own sales and marketing team at the beginning of the year, TSO3 strengthened it by recruiting sales representatives for the commercialization of the 125L Ozone Sterilizer in North America.

- Eight 125L Ozone sterilizers and associated accessories were sold in the United States and Canada.

- The FDA authorized the utilization of the 125L Ozone Sterilizer for sterilizing a significantly broader range of lumened instruments that are longer and with smaller interior diameters. Thus, TSO3’s technology redefines sterilization standards and is put even further ahead of the competition.

- After several years of effort and waiting, TSO3’s ozone sterilization process is patented in Europe and the United States. This patent covers the ozone sterilization method and the process of creating humidity at low temperatures – a process exclusive to the Company and necessary for effective sterilization.

- New medical instrument manufacturers endorsed the Company’s technology and thus confirm the 125L Ozone Sterilizer is safe and compatible with their products.

To view the entire release, as well as the management discussion and analysis, click here.
© 2005-2008 TSO3. All Rights Reserved.